The Organogenesis Holdings (NASDAQ:ORGO) Share Price Is Up 330% And Shareholders Are Delighted

While some are satisfied with an index fund, active investors aim to find truly magnificent investments on the stock market. When you find (and hold) a big winner, you can markedly improve your finances. In the case of Organogenesis Holdings Inc. (NASDAQ:ORGO), the share price is up an incredible 330% in the last year alone. On top of that, the share price is up 173% in about a quarter. Organogenesis Holdings hasn't been listed for long, so it's still not clear if it is a long term winner.

View our latest analysis for Organogenesis Holdings

Organogenesis Holdings wasn't profitable in the last twelve months, it is unlikely we'll see a strong correlation between its share price and its earnings per share (EPS). Arguably revenue is our next best option. Shareholders of unprofitable companies usually expect strong revenue growth. That's because it's hard to be confident a company will be sustainable if revenue growth is negligible, and it never makes a profit.

Over the last twelve months, Organogenesis Holdings' revenue grew by 22%. That's a fairly respectable growth rate. Arguably it's more than reflected in the truly wondrous share price gain of 330% in the last year. While we are always careful about jumping on a hot stock too late, there's certainly good reason to keep an eye on Organogenesis Holdings.

The image below shows how earnings and revenue have tracked over time (if you click on the image you can see greater detail).

We consider it positive that insiders have made significant purchases in the last year. Having said that, most people consider earnings and revenue growth trends to be a more meaningful guide to the business. If you are thinking of buying or selling Organogenesis Holdings stock, you should check out this free report showing analyst profit forecasts.

A Different Perspective

It's nice to see that Organogenesis Holdings shareholders have gained 330% over the last year. A substantial portion of that gain has come in the last three months, with the stock up 173% in that time. This suggests the company is continuing to win over new investors. It's always interesting to track share price performance over the longer term. But to understand Organogenesis Holdings better, we need to consider many other factors. To that end, you should be aware of the 4 warning signs we've spotted with Organogenesis Holdings .

If you like to buy stocks alongside management, then you might just love this free list of companies. (Hint: insiders have been buying them).

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on US exchanges.

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.